Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness of statins.

J P Reckless1

  • 1Department of Endocrinology, Diabetes & Metabolism, Royal United Hospital, Bath, UK. mpsjpdr@bath.ac.uk

Current Opinion in Lipidology
|August 17, 2000
PubMed
Summary

Statins effectively lower lipids and are cost-effective for preventing heart disease. However, widespread use for common risk factors may strain healthcare resources.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.

Cardiology·2008
Same author

Actos (pioglitazone): a new treatment for type 2 diabetes.

Hospital medicine (London, England : 1998)·2001
Same author

Difficult insulinoma.

Journal of the Royal Society of Medicine·2001
Same author

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.

Clinical therapeutics·2001
Same author

Pioglitazone.

International journal of clinical practice·2001
Same author

Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease.

Annals of the rheumatic diseases·2000

Area of Science:

  • Cardiovascular Medicine
  • Pharmacoeconomics

Background:

  • Lipid-lowering therapies, particularly statins, are established interventions for cardiovascular disease.
  • Statins have demonstrated efficacy in both secondary and primary prevention of coronary heart disease.
  • Cost-effectiveness analyses support statin use in managing cardiovascular risk.

Purpose of the Study:

  • To evaluate the economic implications of widespread statin use.
  • To assess the impact of targeting high-risk groups for cardiovascular disease prevention.

Main Methods:

  • Review of indirect estimations and long-term randomized trials.
  • Analysis of cost-effectiveness in primary and secondary prevention.
  • Consideration of absolute risk calculation for targeted care.

Main Results:

  • Statin therapy is proven effective and cost-effective for coronary heart disease prevention.
  • Efficient care targeting high-risk individuals is crucial.
  • The high prevalence of coronary heart disease and risk factors poses a significant challenge to healthcare resources.

Conclusions:

  • While statins are effective and cost-effective, their broad application necessitates careful resource allocation.
  • Managing cardiovascular disease requires balancing intervention efficacy with healthcare system capacity.

Related Experiment Videos